“…It should be noted that although one would expect a younger age at diagnosis in the group diagnosed after 2001, there was no such finding in our cohort. The stage at diagnosis is consistently found to be the most important prognostic factor for disease progression and survival (4,5,6,12,22,23,32), so, at least for the sporadic cases, the diagnosis at an earlier stage is favorable for the outcome of the disease. Indeed, Bergholm et al (33), in a study performed in Sweden, have reported that patients in stages I and II have a relative survival similar to the general population.…”